Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T93945 | Target Info | |||
Target Name | Caveolin 1 (CAV1) | ||||
Synonyms | Caveolin1; Caveolin-1; Cav-1 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | CAV1 | ||||
Biochemical Class | Caveolin protein | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 1 Acid anhydride hydrolases | + | |||
Interacting Target Name | Valosin-containing protein p97 (VCP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Valosin-containing protein; Transitional endoplasmic reticulum ATPase; TER ATPase; 15S Mg(2+)-ATPase p97 subunit | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Co-localization | [1] | |||
4 | Reconstituted Complex | [2] | |||
Alpha-type channels | [+] 1 Alpha-type channels | + | |||
Interacting Target Name | Voltage-gated potassium channel Kv1.3 (KCNA3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Voltage-gated potassium channel subunit Kv1.3; Voltage-gated Kv1.3 K(+) channel; Voltage-gated K(+) channel Kv1.3; Potassium channel Kv1.3; KCNA3; HuKIII; HPCN3; HLK3; HGK5 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [3] | |||
2 | Affinity Capture-Western | [4] | |||
3 | Fluorescence Resonance Energy Transfer | [4] | |||
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Protein Name | Caveolin-2 (CAV2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CAV | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Co-fractionation | [6] | |||
Ester hydrolases | [+] 3 Ester hydrolases | + | |||
Interacting Target Name | Protein-tyrosine phosphatase SHP-2 (PTPN11) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein phosphatase non-receptor type 11; SH-PTP3; SH-PTP2; SHPTP2; SHP-2; SHP2; PTP-2C; PTP2C; PTP-1D; Protein-tyrosine phosphatase SHP2; Protein-tyrosine phosphatase 2C; Protein-tyrosine phosphatase 1D | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Reconstituted Complex | [7] | |||
3 | Reconstituted Complex | [8] | |||
Interacting Target Name | Serine/threonine PP2A-alpha (PPP2CA) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform; RP-C; Replication protein C; PP2A-alpha | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Reconstituted Complex | [10] | |||
Interacting Target Name | Phospholipase D2 (PLD2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PLD1C; PLD 2; Phosphatidylcholine-hydrolyzing phospholipase D2; hPLD2; Choline phosphatase 2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Co-fractionation | [12] | |||
G-protein-coupled receptors | [+] 1 G-protein-coupled receptors | + | |||
Interacting Target Name | Proteinase activated receptor 1 (F2R) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TR; Thrombin receptor; Proteinase-activated receptor 1; Protease-activated receptor-1; Protease activated receptor 1; PAR-1; PAR1; Coagulation factor II receptor; CF2R | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Co-fractionation | [13] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [14] | |||
2 | Affinity Capture-Western | [15] | |||
3 | Affinity Capture-Western | [16] | |||
4 | Co-fractionation | [17] | |||
5 | Protein-Fragment Complementation Assay | [18] | |||
6 | Reconstituted Complex | [17] | |||
7 | Yeast two hybrid | [19] | |||
Interacting Target Name | Tyrosine-protein kinase CSK (CSK) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein-tyrosine kinase CYL; C-Src kinase | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Reconstituted Complex | [7] | |||
3 | Yeast two hybrid | [20] | |||
Nuclear hormone receptors | [+] 2 Nuclear hormone receptors | + | |||
Interacting Target Name | Peroxisome proliferator-activated receptor gamma (PPAR-gamma) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor PPAR gamma receptor; PPAR-gamma; PPARgamma; Peroxisome proliferator-activated receptor gamma; Nuclear receptor subfamily 1 group C member 3; NR1C3 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Co-fractionation | [21] | |||
3 | Co-localization | [21] | |||
4 | Yeast two hybrid | [21] | |||
Interacting Target Name | Estrogen receptor (ESR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oestrogen receptor alpha; Oestrogen receptor; Nuclear receptor subfamily 3 group A member 1; NR3A1; Estrogen receptor alpha; Estradiol receptor; ESR; ER-alpha; ERalpha; ER | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Co-localization | [23] | |||
3 | Reconstituted Complex | [22] | |||
Oxidoreductases | [+] 1 Oxidoreductases | + | |||
Interacting Target Name | Prostaglandin G/H synthase 2 (COX-2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Prostaglandin-endoperoxide synthase 2; Prostaglandin H2 synthase 2; PHS II; PGHS-2; PGH synthase 2; Cytochrome c oxidase polypeptide II; Cyclooxygenase-2; COX2 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [24] | |||
2 | Affinity Capture-Western | [25] | |||
3 | Affinity Capture-Western | [2] | |||
4 | Co-fractionation | [24] | |||
5 | Reconstituted Complex | [24] | |||
6 | Reconstituted Complex | [2] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Ubiquitination of the N-terminal region of caveolin-1 regulates endosomal sorting by the VCP/p97 AAA-ATPase. J Biol Chem. 2013 Mar 8;288(10):7363-72. | ||||
REF 2 | Caveolin-1 interacts with Derlin-1 and promotes ubiquitination and degradation of cyclooxygenase-2 via collaboration with p97 complex. J Biol Chem. 2013 Nov 15;288(46):33462-9. | ||||
REF 3 | Kv1.5 association modifies Kv1.3 traffic and membrane localization. J Biol Chem. 2008 Mar 28;283(13):8756-64. | ||||
REF 4 | Caveolin interaction governs Kv1.3 lipid raft targeting. Sci Rep. 2016 Mar 2;6:22453. | ||||
REF 5 | Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem. 1997 Nov 14;272(46):29337-46. | ||||
REF 6 | Serine 23 and 36 phosphorylation of caveolin-2 is differentially regulated by targeting to lipid raft/caveolae and in mitotic endothelial cells. Biochemistry. 2008 Jan 8;47(1):101-11. | ||||
REF 7 | SHP-2 binds to caveolin-1 and regulates Src activity via competitive inhibition of CSK in response to H2O2 in astrocytes. PLoS One. 2014 Mar 14;9(3):e91582. | ||||
REF 8 | Protein-protein interaction between caveolin-1 and SHP-2 is dependent on the N-SH2 domain of SHP-2. BMB Rep. 2015 Mar;48(3):184-9. | ||||
REF 9 | Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. J Biol Chem. 2007 Nov 16;282(46):33284-94. | ||||
REF 10 | Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol Cell Biol. 2003 Dec;23(24):9389-404. | ||||
REF 11 | Aquaporin 3 colocates with phospholipase d2 in caveolin-rich membrane microdomains and is downregulated upon keratinocyte differentiation. J Invest Dermatol. 2003 Dec;121(6):1487-95. | ||||
REF 12 | Phospholipase D2: functional interaction with caveolin in low-density membrane microdomains. FEBS Lett. 2000 Feb 11;467(2-3):326-32. | ||||
REF 13 | Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells. J Thromb Haemost. 2007 Dec;5(12):2437-44. | ||||
REF 14 | Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation ... Mol Cell Proteomics. 2006 Sep;5(9):1610-27. | ||||
REF 15 | Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J Physiol Renal Physiol. 2003 Feb;284(2):F303-12. | ||||
REF 16 | Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. J Biol Chem. 2000 Jul 7;275(27):20847-52. | ||||
REF 17 | Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae. Oncogene. 2004 Sep 9;23(41):6967-79. | ||||
REF 18 | The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92. | ||||
REF 19 | In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84. | ||||
REF 20 | A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase. J Biol Chem. 2002 Mar 15;277(11):8771-4. | ||||
REF 21 | The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor through spatial relocalization at helix 7 of its ligand-binding domain. Mol Cell Biol. 2011 Aug;31(16):3497-510. | ||||
REF 22 | Ligand-independent activation of oestrogen receptor alpha by caveolin-1. Biochem J. 2001 Oct 1;359(Pt 1):203-10. | ||||
REF 23 | Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor- interactions with G protein-i and caveolin I. Steroids. 2012 Apr;77(5):424-32. | ||||
REF 24 | Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem. 2001 Sep 14;276(37):34975-82. | ||||
REF 25 | Caveolin-1 facilitates cyclooxygenase-2 protein degradation. J Cell Biochem. 2010 Feb 1;109(2):356-62. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.